BC Biotech Company Combating Diseases with Nanotechnology
A B.C.-based life sciences company that has created a platform to develop nanotechnology-based delivery systems to carry drugs directly to diseased tissues and into human cells is now preparing for rapid expansion into international markets.
< Back to Success Stories
Precision NanoSystems Inc. (PNI) is a manufacturer of instruments, kits and reagents in the global nanomedicine market, providing tools for drug development and cell-specific delivery to study, diagnose and treat disease. Nanomedicines use nanotechnology to deliver drugs directly to diseased tissues and into disease cells, enabling the drug to have its effect in the right place and at the right time. The company has developed their NanoAssemblrTM suite of instruments that allows biopharmaceutical companies and research organizations to rapidly develop novel nanomedicines for therapeutic and diagnostic uses. PNI’s flagship product, the NanoAssemblr™ Benchtop instrument, allows scientists to engineer novel nanomedicine drug candidates. PNI has sold more than 80 NanoAssemblr Benchtop instruments worldwide to leading pharmaceutical and biotechnology companies as well as several elite academic institutions.
With several million dollars in private financing announced earlier this year from biotech venture capital firms and private investors, PNI is poised for rapid expansion. They recently opened a subsidiary office in the United Kingdom with the Ministry of International Trade’s UK-based team providing support and connecting them with relevant stakeholders.
PNI is just one of the many companies that make up the diverse life sciences sector in British Columbia. With more than 300 biopharmaceutical and medical device companies, British Columbia has a thriving life sciences sector offering investment opportunities in life sciences products and services.
A steady stream of innovation also flows into the industry, thanks to the array of high calibre educational institutions. The University of British Columbia alone has founded more than 20 companies and worked with local and global industry partners to commercialize more than 80 technologies. These companies benefit from being in the same time zone as the scientific community in Washington State and California. British Columbia’s strategic location means they can also connect with both Asia and Europe in the same business day.
For more information on British Columbia’s life sciences sector or to learn more about our services please contact one of our International Trade and Investment Representatives.
Posted on: July 20, 2016